Zhou EH, et al. – Study authors wanted to illustrate the US Food and Drug Administration's (FDA's) drug safety recommendations and long–acting beta2–agonist dispensing pattern changes in adult asthma patients. The decrease in SI–long-acting beta2-agonist (LABA) initiation was consistent with FDA’s recommendations. However, low inhaled corticosteroid (ICS) dispensing before initiating a LABA and LABA continuation practices required further efforts to move toward the recommended safe practices.